US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qudian Inc.

2.47

-0.0500-1.98%

Volume:965.74K

Turnover:2.39M

Market Cap:467.83M

PE:92.11

High:2.53

Open:2.50

Low:2.41

Close:2.52

Loading ...

Overview Company News Filings

Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading

MT Newswires Live

Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio

Qudian Up Over 22%, On Pace for Highest Close Since March 2021 -- Data Talk

Qudian Third Quarter 2024 Earnings: EPS: CN¥0.73 (vs CN¥0.84 loss in 3Q 2023)

Simply Wall St.

Qudian: Q3 Earnings Snapshot

Associated Press Finance

BRIEF-Qudian Reports Third Quarter 2024 Unaudited Financial Results

Qudian Q3 Adj. EPADS $0.10 Up From $(0.11) YoY, Sales $7.80M Up From $4.06M YoY

Qudian Q3 Income From Operations RMB -66.983 Million

THOMSON REUTERS

Qudian Incl: Qtrly Adj Net Income per Diluted Ads RMB0.71

THOMSON REUTERS

QD Laser Sets Profitability Goal by Fiscal Year 2027 in Mid-Term Plan

MT Newswires Live

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

Oxbridge Re Holdings Among 3 US Penny Stocks To Watch

Simply Wall St.

Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024

QD Laser 1H Parent Loss Y303.00M Vs Loss Y250.00M

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/QD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","market":"US","secType":"STK","nameCN":"Qudian Inc.","latestPrice":2.47,"timestamp":1745265600000,"preClose":2.52,"halted":0,"volume":965744,"delay":0,"floatShares":121052982,"shares":189403851,"eps":0.026816,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"04-22 07:55:30 EDT","open":2.5,"high":2.53,"low":2.41,"amount":2389556.6036992,"amplitude":0.047619,"askPrice":2.73,"askSize":100,"bidPrice":2.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.026816,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1508299200000,"exchange":"NYSE","adjPreClose":2.47,"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.47,"latestTime":"17:19 EDT","volume":580417,"amount":1433629.99,"timestamp":1745270347914},"volumeRatio":1.561115274722613,"impliedVol":0.9848,"impliedVolPercentile":0.8193},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","floatShares":121052982,"roa":"-1.34%","roe":"0.35%","lyrEps":0.025399,"volumeRatio":1.561115274722613,"shares":189403851,"dividePrice":0,"high":2.53,"amplitude":0.047619,"preClose":2.52,"low":2.41,"week52Low":1.52,"pbRate":"0.30","psRate":"15.01","week52High":3.34,"institutionHeld":0,"latestPrice":2.47,"eps":0.026816,"divideRate":0,"volume":965744,"delay":0,"ttmEps":0.026816,"open":2.5,"prevYearClose":2.82,"prevWeekClose":2.52,"prevMonthClose":2.69,"prevQuarterClose":2.69,"fiveDayClose":2.37,"twentyDayClose":2.84,"sixtyDayClose":2.93},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490723784","title":"Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490723784","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490723784?lang=en_us&edition=fundamental","pubTime":"2024-12-09 19:30","pubTimestamp":1733743800,"startTime":"0","endTime":"0","summary":"Observed an antiviral effect for the primary and secondary virology endpoints in the overall population, with a viral load decline of 1.4 log at the end of treatment in Part 2. Demonstrated a viral load decline of 1.2 log compared to placebo at the end of treatment in prespecified analysis of patients randomized within 3 days of symptom onset. Zelicapavir was well-tolerated with a favorable safety profile. \"In my practice, I see many children requiring hospitalization for severe RSV infection during the RSV season. The impact of RSV is felt not only by patients and caregivers, but also broadly by public health. I believe that a safe and effective ant","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rbfaFpZVEXeQ6zSOYvPFjg--~B/aD03MzI7dz0yMTkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e100d2a51b79475e8239f419043a0e9f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rbfaFpZVEXeQ6zSOYvPFjg--~B/aD03MzI7dz0yMTkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e100d2a51b79475e8239f419043a0e9f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enanta-pharmaceuticals-announces-positive-topline-113000286.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","QD","BK4139","BK4503","BK4166","ENTA"],"gpt_icon":0},{"id":"2490487753","title":"C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader","url":"https://stock-news.laohu8.com/highlight/detail?id=2490487753","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490487753?lang=en_us&edition=fundamental","pubTime":"2024-12-09 01:30","pubTimestamp":1733679000,"startTime":"0","endTime":"0","summary":"In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved 36 Percent Overall Response Rate (ORR) and 45 Percent Clinical Benefit Rate (CBR); Re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/08/2993401/0/en/C4-Therapeutics-Presents-Cemsidomide-Phase-1-Data-at-the-American-Society-for-Hematology-ASH-Annual-Meeting-that-Demonstrated-Potential-to-Become-Best-in-Class-IKZF1-3-Degrader.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFG","CCCC","LENZ","BK4117","BK4109","BK4139","QD","LU2463526074.USD","BK4503","BK4166","BK4563","ASH","BK4107"],"gpt_icon":0},{"id":"2489269372","title":"Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2489269372","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489269372?lang=en_us&edition=fundamental","pubTime":"2024-12-07 05:01","pubTimestamp":1733518860,"startTime":"0","endTime":"0","summary":"– OLE data shows sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and consistent AE safety profile suggesting long-term efficacy and tolerability of azetukalner – Ap","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/06/2993260/33485/en/Xenon-Showcases-New-Long-Term-Azetukalner-Data-from-X-TOLE-OLE-Study-in-FOS-at-AES-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU0300736492.USD","LU1093756325.SGD","IE00B19Z3B42.SGD","BK4585","IE00B19Z3581.USD","LU0170899867.USD","BK4138","IE00BSNM7G36.USD","MPC","LU0061475181.USD","IE0002270589.USD","BK4563","BK4588","LU0122376428.USD","LU0266512127.USD","LU0456854461.SGD","BK4105","BK4166","AES","LU1093756168.USD","QD","LU0788109394.HKD","LU0300736062.USD","BK4503","BK4519","LU0368265418.SGD"],"gpt_icon":0},{"id":"2488224917","title":"Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2488224917","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488224917?lang=en_us&edition=fundamental","pubTime":"2024-12-03 21:30","pubTimestamp":1733232600,"startTime":"0","endTime":"0","summary":"First program to result from end-to-end use of OS to identify a novel target and new chemical matter, which moved from target ID to IND enabling studies in under 18 months with ~200 compounds synthesi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/03/2990639/0/en/Recursion-announces-first-patient-dosed-in-Phase-1-2-clinical-study-of-REC-1245-a-potential-first-in-class-RBM39-degrader-for-Biomarker-Enriched-Solid-Tumors-and-Lymphoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","OS","BK4121","BK4139","LU1093756325.SGD","LU2413666699.HKD","BK4567","LU1093756168.USD","LU0347712357.USD","BK4503","LU1721428933.USD","BK4585","LU2413666426.HKD","RXRX","BK4548","QD","BK4097","MTD","BK4166","BK4539","BK4533","BK4588"],"gpt_icon":1},{"id":"2488608696","title":"Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2488608696","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488608696?lang=en_us&edition=fundamental","pubTime":"2024-12-02 23:40","pubTimestamp":1733154046,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were sharply higher Monday morning, rising 1.43% to 2,074.10 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by solar panel maker JinkoSolar  and solar project developer Emeren Group , which rose 11.7% and 2.4% respectively. They were followed by online game developer The9  and used car ecommerce platform Uxin , up 5.8% and 2.5% respectively.The decliners from North Asia were led by credit-tech platform Qifu Technology  and healthcare platform 111 , which dropped 5.1% and 2.6% respectively. They were followed by utilities company Korea Electric Power  and consumer lending firm Qudian , which fell 4.6% and 4.3% respectively.From South Asia, the gainers were led by telecommunications operator PLDT , which rose 1.2%, followed by pharmaceutical company Dr. Reddy's Laboratories  and IT firm Infosys , which increased 1.3% and 0.2% respectively.The decliners from South Asia were led by telecommunications operat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4128","BK4141","SIFY","BK4519","RDY","BK4557","LU0531971678.HKD","BK4532","PHI","RDY.AU","UXIN","BK7083","YI","KEP","BK4134","QFIN","LU0708995666.HKD","LU0890818403.SGD","BK4007","BK4535","BK4122","BK4107","JKS","BK4023","LU0868486357.SGD","IE00B0JY6M65.USD","BK4596","LU2476274308.USD","LU1805238398.USD","NCTY","BK4503","LU2087589342.USD","BK4526","LU0862451753.SGD","BK4588","LU1366334578.USD","BK4129","QD","LU1366334651.USD","SOL","SOL.AU","TLK","INFY","LU0431992006.USD","AFG","BK4585","BK4531","LU0164881194.USD","BK4115","LU1804176565.USD"],"gpt_icon":0},{"id":"2488637675","title":"Revolution Medicines Provides Clinical Updates from its RAS(ON) Inhibitor Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2488637675","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488637675?lang=en_us&edition=fundamental","pubTime":"2024-12-02 20:30","pubTimestamp":1733142600,"startTime":"0","endTime":"0","summary":"Compelling Phase 1/1b update on RMC-6236 monotherapy in second-line metastatic pancreatic ductal adenocarcinoma supports ongoing Phase 3 RASolute 302 clinical trial Phase 1/1b proof-of-concept for RMC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989693/0/en/Revolution-Medicines-Provides-Clinical-Updates-from-its-RAS-ON-Inhibitor-Portfolio.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU1854103824.USD","LU1861220033.SGD","BK4092","LU0266512127.USD","LU2357305700.SGD","BK4585","BK4599","BK4166","IE00BD6J9T35.USD","ALT","LU1548497426.USD","LU1861215975.USD","BK4590","BK4563","BK4141","LU1861219969.SGD","BK4503","BK4581","LU1854104046.USD","BK4139","BK4588","IE00BZ199S13.USD","IE00B19Z3B42.SGD","CRC","LU0868494617.USD","IE00B19Z3581.USD","LU0724618433.USD","QD","AST","BK4213","ON","IE0002270589.USD","CI","LU1878469433.USD","LU1720051108.HKD","LU1059921491.USD","MDCO","LU0124384867.USD","IE00BSNM7G36.USD","ET","LU0289739699.SGD","LU2298322129.HKD","NE","LU0456854461.SGD","RVMD","BK4196","LU1861214812.USD","LU1978683503.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2486687833","title":"Qudian Up Over 22%, On Pace for Highest Close Since March 2021 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2486687833","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486687833?lang=en_us&edition=fundamental","pubTime":"2024-11-27 03:41","pubTimestamp":1732650060,"startTime":"0","endTime":"0","summary":"Qudian, Inc. Sponsored ADR Class A  is currently at $2.80, up $0.51 or 22.31%. --Would be highest close since March 18, 2021, when it closed at $2.92. --On pace for largest percent increase since July 18, 2022, when it rose 40.34%. --Down 91.97% from its all-time closing high of $34.90 on Oct. 19, 2017. --Up 78.41% from 52 weeks ago , when it closed at $1.57. --Up 83.07% from its 52-week closing low of $1.53 on June 12, 2024. --Traded as high as $2.82; highest intraday level since June 18, 2021, when it hit $2.85. --Up 23.14% at today's intraday high; largest intraday percent increase since July 18, 2022, when it rose as much as 83.19%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4166","BK4503","QD"],"gpt_icon":0},{"id":"2485779365","title":"Qudian Third Quarter 2024 Earnings: EPS: CN¥0.73 (vs CN¥0.84 loss in 3Q 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2485779365","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485779365?lang=en_us&edition=fundamental","pubTime":"2024-11-24 20:01","pubTimestamp":1732449718,"startTime":"0","endTime":"0","summary":"NYSE:QD Earnings and Revenue History November 24th 2024. All figures shown in the chart above are for the trailing 12 month  period. Qudian shares are up 1.3% from a week ago.It's necessary to consider the ever-present spectre of investment risk.   We've identified 2 warning signs  with Qudian , and understanding them should be part of your investment process.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qudian-third-quarter-2024-earnings-120158696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","CN"],"gpt_icon":0},{"id":"2485018255","title":"Qudian: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2485018255","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485018255?lang=en_us&edition=fundamental","pubTime":"2024-11-22 19:07","pubTimestamp":1732273649,"startTime":"0","endTime":"0","summary":"XIAMEN, China  — XIAMEN, China  — Qudian Inc.  on Friday reported earnings of $18.8 million in its third quarter.On a per-share basis, the Xiamen, China-based company said it had profit of 10 cents.The online micro-lending company posted revenue of $7.8 million in the period.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qudian-q3-earnings-snapshot-110729013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD"],"gpt_icon":0},{"id":"2485125800","title":"BRIEF-Qudian Reports Third Quarter 2024 Unaudited Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2485125800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485125800?lang=en_us&edition=fundamental","pubTime":"2024-11-22 18:58","pubTimestamp":1732273123,"startTime":"0","endTime":"0","summary":"BRIEF-Qudian Reports Third Quarter 2024 Unaudited Financial ResultsNov 22 (Reuters) - Qudian Inc QD.N:QUDIAN INC. REPORTS THIRD QUARTER 2024 UNAUDITED FINANCIAL RESULTSQUDIAN INCL: QTRLY ADJUSTED  NET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nTUA3ZZQFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","QD","BK4166","BK4563"],"gpt_icon":0},{"id":"2485237832","title":"Qudian Q3 Adj. EPADS $0.10 Up From $(0.11) YoY, Sales $7.80M Up From $4.06M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2485237832","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485237832?lang=en_us&edition=fundamental","pubTime":"2024-11-22 18:04","pubTimestamp":1732269873,"startTime":"0","endTime":"0","summary":"Qudian (NYSE:QD) reported quarterly earnings of $0.10 per share. This is a 190.91 percent increase over losses of $(0.11) per share from the same period last year. The company reported $7.80 million in sales this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/42132994/qudian-q3-adj-epads-0-10-up-from-0-11-yoy-sales-7-80m-up-from-4-06m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Qudian Q3 Adj. EPADS $0.10 Up From $(0.11) YoY, Sales $7.80M Up From $4.06M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QD"],"gpt_icon":0},{"id":"2485923224","title":"Qudian Q3 Income From Operations RMB -66.983 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2485923224","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485923224?lang=en_us&edition=fundamental","pubTime":"2024-11-22 18:00","pubTimestamp":1732269606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nPLXD3BF27:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","QD","BK4503","BK4166"],"gpt_icon":0},{"id":"2485237597","title":"Qudian Incl: Qtrly Adj  Net Income per Diluted Ads RMB0.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2485237597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485237597?lang=en_us&edition=fundamental","pubTime":"2024-11-22 18:00","pubTimestamp":1732269606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nTUA3ZZQFP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4503","BK4166","QD","BK4563"],"gpt_icon":0},{"id":"2485221574","title":"QD Laser Sets Profitability Goal by Fiscal Year 2027 in Mid-Term Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2485221574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485221574?lang=en_us&edition=fundamental","pubTime":"2024-11-22 06:55","pubTimestamp":1732229704,"startTime":"0","endTime":"0","summary":"QD Laser  targets profitability by the fiscal year ending March 2027 with net sales reaching 1.95 billion yen and operating profit of 7 million yen under its baseline plan, according to a Thursday filing on the Tokyo Stock Exchange.The plan focuses on its laser device and visual information device  businesses, aiming for annual growth of 20%-25% in the laser device segment, with improved gross margins of 45% by FY26.The VID business will collaborate with partners to reduce financial burdens while pursuing new products like Smart Glasses and Vision Health Care services. Operating loss is expected at 331 million yen for FY26, with a return to profitability by FY27.Price : $328.00, Change: $+8.0, Percent Change: +2.50%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QD","BK4166","BK4503","BK4563"],"gpt_icon":0},{"id":"2484192072","title":"Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2484192072","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484192072?lang=en_us&edition=fundamental","pubTime":"2024-11-20 20:02","pubTimestamp":1732104120,"startTime":"0","endTime":"0","summary":"-- SRC recommended that the trial escalate to the next dose level of 15mg capsule --. -- No dose-limiting toxicities  observed to date --. Dr. Tiago Reis Marques, Chief Executive Officer of Pasithea stated, “We are pleased to observe that as we continue to dose escalate, we have not yet seen rash emerge. Rash is a common adverse event  that is observed at low doses with competitor MEK inhibitors and may lead to the high discontinuation rate in real world practice. In addition, we are excited to dose patients with our potential commercial formulation.”Pasithea is a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system  disorders and RASopathies. With an experienced team of experts in the fields of neuroscience, translational medicine, and drug development, Pasithea is developing new molecular entities for the treatment of neurologi","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gIokpGPCXewyfjJRBhDTxw--~B/aD0xNjE7dz0zMzg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/73304d1b574477de471e2e9a4a8c2e2c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gIokpGPCXewyfjJRBhDTxw--~B/aD0xNjE7dz0zMzg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/73304d1b574477de471e2e9a4a8c2e2c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pasithea-therapeutics-announces-positive-safety-120200893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PK","BK4135","LU1169590202.USD","AEIS","KTTA","BK4166","BK4563","BK4503","PD","IE0031619046.USD","KTTAW","BK4139","IE00B7SZL793.SGD","BK4157","CNS","QD","IE00B66KJ199.SGD","BK4023","BK4080","BK4231","AE","BK4181","SRC","BK4138","BK4218","IE00B19Z4B17.USD","LENZ","LU1169589451.USD"],"gpt_icon":1},{"id":"2484941868","title":"Oxbridge Re Holdings Among 3 US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2484941868","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484941868?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:04","pubTimestamp":1732021486,"startTime":"0","endTime":"0","summary":"The U.S. stock market has recently shown signs of recovery, with the S&P 500 and Nasdaq Composite rebounding after a challenging week, highlighting the resilience of equities amid fluctuating investor sentiment. Penny stocks may be an older term, but they continue to offer intriguing investment opportunities by allowing investors to access potential growth in smaller or newer companies at lower price points. When these stocks are supported by strong financial health and solid fundamentals, they can present a compelling case for those seeking value in less conventional areas of the market.Overview: Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company focused on developing and investing in therapeutics for mental health disorders such as depression, anxiety, and addiction, with a market cap of approximately $270.16 milli","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oxbridge-holdings-among-3-us-130446188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4019","BABB","BK4166","BK4209","BK4075","BK4007","BK4551","OXBR","QD","BK4539","BK4213","OXBRW","BK4563","ATAI","PHX","BK4503","RLX","BK4526"],"gpt_icon":0},{"id":"2483130645","title":"Atea Pharmaceuticals Presents Multiple New Datasets Supporting the Combination of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at AASLD’s The Liver Meeting 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483130645","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483130645?lang=en_us&edition=fundamental","pubTime":"2024-11-16 00:00","pubTimestamp":1731686400,"startTime":"0","endTime":"0","summary":"BOSTON, Nov. 15, 2024  -- Atea Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today presented three poster presentations supporting the combination of bemnifosbuvir and ruzasvir as a potential treatment for hepatitis C virus . The combination of bemnifosbuvir, a nucleotide analog polymerase inhibitor, and ruzasvir, an NS5A inhibitor, is in Phase 2 development for the treatment of HCV. These data are being presented at the American Association for the Study of Liver Diseases’  The Liver Meeting 2024, being held from November 15-19, 2024 in San Diego, CA.A multiscale HCV viral kinetic model was utilized to estimate the clinical effectiveness of the combination of bemnifosbuvir and ruzasvir in blocking HCV replication and viral assembly/secretion against HCV. This model evaluated the combination of bemnifosbuvir and ruzasvir in the lead-in cohort  of a Phase 2 single-ar","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/R_jy000qdGewQIJiD_sBaA--~B/aD01MTM7dz05MDQ7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/8af90bcf7484416abf6a1ff458b8f218"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atea-pharmaceuticals-presents-multiple-datasets-160000655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4503","SOF","BK4166","AVIR","LU1878469433.USD","PK","BK4181","QD","BK4218","BK4563","ALT","BK4139"],"gpt_icon":0},{"id":"2483845882","title":"QD Laser 1H Parent Loss Y303.00M Vs Loss Y250.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2483845882","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483845882?lang=en_us&edition=fundamental","pubTime":"2024-11-14 15:30","pubTimestamp":1731569400,"startTime":"0","endTime":"0","summary":"QD Laser Inc.  Japan Half-Year Ended September 30 PARENT20242023 RevenueY559.00 mlnY638.00 mln Operating Profit Pretax Profit Net Profit Per share Earnings Dividend First quarterN/AN/A MidyearY0.00Y0.00 Third quarterN/AN/A Year-endY0.00Y0.00 AnnualY0.00Y0.00 Figures in parentheses are losses. Results are based on Japanese accounting standards. Dividends for periods in the future are forecasts.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","BK4166","BK4563","QD"],"gpt_icon":0},{"id":"2483526010","title":"Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483526010","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483526010?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:05","pubTimestamp":1731445500,"startTime":"0","endTime":"0","summary":"Interim data from initial dose escalation cohorts of Phase 1 CARDINAL trial evaluating TERN-701  in chronic myeloid leukemia  expected in early December 2024. Plans to initiate Phase 2 clinical trial for TERN-601 in obesity in early 2Q25 with initial 12-week data expected in 2H25. Cash, cash equivalents and marketable securities of $372.8 million, including $172.7 million equity raise in September, expected to provide runway into 2028. FOSTER CITY, Calif., Nov. 12, 2024  -- Terns Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today reported financial results for the third quarter ended September 30, 2024, and provided corporate updates.TERN-701: Oral, allosteric BCR-ABL tyrosine kinase inhibitor  for chronic myeloid leukemia . Interim data from initial dose escalation cohorts in Terns’ ongoing Phase 1 CARDINAL study of TERN-701 in CML expected in","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B6BCQsYDKvl65S1UDszPGQ--~B/aD00NDU7dz0xMTQ3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/611bda6becb939fc9cd754fdd8c57d0a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B6BCQsYDKvl65S1UDszPGQ--~B/aD00NDU7dz0xMTQ3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/611bda6becb939fc9cd754fdd8c57d0a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/terns-pharmaceuticals-reports-third-quarter-210500879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","GIPR","PK","BK4007","BK4563","BK4166","BK4181","BK4218","TERN","BK4160","BK4503"],"gpt_icon":0},{"id":"2481870191","title":"Tyra Biosciences Reports Third Quarter 2024 Financial Results and Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2481870191","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481870191?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:05","pubTimestamp":1731013500,"startTime":"0","endTime":"0","summary":"- Reported positive interim clinical proof-of-concept results for TYRA-300 in mUC from SURF301 Ph1/2 study -. - IND cleared for Phase 2 study of TYRA-300 in pediatric achondroplasia  -. CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor  biology, today reported financial results for the quarter ended September30, 2024, and highlighted recent corporate progress.Phase 2IND Submission for NMIBC on Track for Year-End 2024. TYRA plans to expand the clinical development of TYRA-300 into NMIBC to address the unmet needs in this can","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/14NqX0.RJgyZke145_EJTw--~B/aD0xNjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/38a561c6850218e47560162fca1bdb04","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/14NqX0.RJgyZke145_EJTw--~B/aD0xNjQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/38a561c6850218e47560162fca1bdb04"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tyra-biosciences-reports-third-quarter-210500284.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tyra-biosciences-reports-third-quarter-210500284.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1093756168.USD","BK4548","TYRA","ACH","BK4563","CMO","BK4121","BK4588","BK4585","BK4567","LU2413666699.HKD","QD","BK4503","LU1721428933.USD","BK4166","MTD","BK4139","BK4213","BK4006","PR","BK4533","LU2413666426.HKD","HCC","LU0347712357.USD","LU1093756325.SGD","BK4153"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"QD","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-11-22","symbol":"QD","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1732251600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2024-09-06","symbol":"QD","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725595200000,"reportTimeType":"pre","actualEps":0.07},{"market":"US","date":"2024-06-13","symbol":"QD","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1718251200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-03-18","symbol":"QD","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"pre","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QD","date":"2025-04-21","current":84.840561,"percent":0.897727,"low":-88.607914,"twenty":-4.50361,"median":1.982513,"eighty":16.352149,"high":110.235059,"avg":11.007716,"sd":34.472767,"marketCap":477297704},"quantilePoints":[{"date":"2020-04-24","current":0.890791,"twenty":3.206684,"median":4.955908,"eighty":9.830591,"marketCap":410602488},{"date":"2020-05-01","current":0.878138,"twenty":2.284286,"median":4.944031,"eighty":9.808673,"marketCap":405950457},{"date":"2020-05-08","current":0.962192,"twenty":2.215217,"median":4.934765,"eighty":9.770965,"marketCap":444008313},{"date":"2020-05-15","current":0.910759,"twenty":2.195189,"median":4.927236,"eighty":9.748922,"marketCap":418636409},{"date":"2020-05-22","current":0.831163,"twenty":2.178041,"median":4.907052,"eighty":9.736972,"marketCap":380578554},{"date":"2020-05-29","current":1.485647,"twenty":2.15827,"median":4.857685,"eighty":9.731582,"marketCap":380578554},{"date":"2020-06-05","current":1.513828,"twenty":2.111924,"median":4.836038,"eighty":9.713673,"marketCap":390727315},{"date":"2020-06-12","current":1.494313,"twenty":2.077217,"median":4.820821,"eighty":9.690916,"marketCap":385652934},{"date":"2020-06-19","current":1.697674,"twenty":2.054702,"median":4.802938,"eighty":9.676676,"marketCap":438933932},{"date":"2020-06-26","current":1.709075,"twenty":1.997591,"median":4.760441,"eighty":9.653813,"marketCap":441471122},{"date":"2020-07-02","current":1.68657,"twenty":1.963896,"median":4.75815,"eighty":9.642907,"marketCap":436396741},{"date":"2020-07-10","current":2.312239,"twenty":1.963896,"median":4.748623,"eighty":9.604742,"marketCap":603851305},{"date":"2020-07-17","current":1.97954,"twenty":1.963896,"median":4.718462,"eighty":9.559259,"marketCap":517586833},{"date":"2020-07-24","current":1.616747,"twenty":1.918817,"median":4.713887,"eighty":9.538168,"marketCap":421173599},{"date":"2020-07-31","current":1.568191,"twenty":1.76894,"median":4.700634,"eighty":9.522584,"marketCap":411024838},{"date":"2020-08-07","current":1.614876,"twenty":1.736998,"median":4.673639,"eighty":9.493529,"marketCap":423710790},{"date":"2020-08-14","current":1.755578,"twenty":1.705998,"median":4.644245,"eighty":9.483072,"marketCap":461768645},{"date":"2020-08-21","current":1.622789,"twenty":1.673427,"median":4.641146,"eighty":9.471666,"marketCap":428785170},{"date":"2020-08-28","current":1.591166,"twenty":1.651695,"median":4.639855,"eighty":9.458685,"marketCap":423710790},{"date":"2020-09-04","current":1.471861,"twenty":1.642989,"median":4.637355,"eighty":9.446127,"marketCap":393264505},{"date":"2020-09-11","current":2.9708,"twenty":1.644704,"median":4.630228,"eighty":9.441013,"marketCap":375519436},{"date":"2020-09-18","current":2.763282,"twenty":1.645206,"median":4.617694,"eighty":9.438537,"marketCap":352683795},{"date":"2020-09-25","current":2.544944,"twenty":1.64953,"median":4.600475,"eighty":9.427936,"marketCap":322236273},{"date":"2020-10-02","current":2.612554,"twenty":1.651477,"median":4.596099,"eighty":9.420407,"marketCap":332385447},{"date":"2020-10-09","current":2.75249,"twenty":1.651881,"median":4.578229,"eighty":9.392619,"marketCap":355221088},{"date":"2020-10-16","current":2.537281,"twenty":1.658807,"median":4.56539,"eighty":9.362569,"marketCap":327310860},{"date":"2020-10-23","current":3.004667,"twenty":1.665444,"median":4.549138,"eighty":9.317241,"marketCap":388205903},{"date":"2020-10-30","current":2.632757,"twenty":1.672076,"median":4.545601,"eighty":9.282307,"marketCap":339997327},{"date":"2020-11-06","current":2.718404,"twenty":1.683941,"median":4.537883,"eighty":9.247967,"marketCap":355221088},{"date":"2020-11-13","current":3.007111,"twenty":1.690294,"median":4.530427,"eighty":9.222351,"marketCap":393280490},{"date":"2020-11-20","current":2.891564,"twenty":1.696384,"median":4.514509,"eighty":9.207035,"marketCap":380594023},{"date":"2020-11-27","current":2.781782,"twenty":1.702668,"median":4.503584,"eighty":9.203814,"marketCap":365370262},{"date":"2020-12-04","current":2.64678,"twenty":1.707844,"median":4.491432,"eighty":9.193684,"marketCap":350146501},{"date":"2020-12-11","current":2.557096,"twenty":1.724561,"median":4.482553,"eighty":9.147292,"marketCap":337460034},{"date":"2020-12-18","current":5.102651,"twenty":1.736153,"median":4.48545,"eighty":9.115708,"marketCap":322236273},{"date":"2020-12-24","current":4.937025,"twenty":1.737666,"median":4.491432,"eighty":9.10861,"marketCap":312087099},{"date":"2020-12-31","current":5.537487,"twenty":1.740124,"median":4.502956,"eighty":9.092785,"marketCap":350146501},{"date":"2021-01-08","current":6.444668,"twenty":1.747874,"median":4.514509,"eighty":9.047388,"marketCap":411041545},{"date":"2021-01-15","current":7.208537,"twenty":1.758064,"median":4.530427,"eighty":9.019783,"marketCap":459250121},{"date":"2021-01-22","current":8.445492,"twenty":1.768009,"median":4.537043,"eighty":8.984768,"marketCap":537906219},{"date":"2021-01-29","current":7.942919,"twenty":1.76894,"median":4.542259,"eighty":8.938442,"marketCap":509995991},{"date":"2021-02-05","current":11.924246,"twenty":1.851142,"median":4.548275,"eighty":9.028537,"marketCap":761188047},{"date":"2021-02-12","current":14.445936,"twenty":1.868824,"median":4.559967,"eighty":9.120701,"marketCap":923574830},{"date":"2021-02-19","current":12.380316,"twenty":1.88933,"median":4.571167,"eighty":9.207035,"marketCap":791635568},{"date":"2021-02-26","current":8.51412,"twenty":1.913945,"median":4.592159,"eighty":9.247967,"marketCap":542980806},{"date":"2021-03-05","current":8.703275,"twenty":1.943752,"median":4.599299,"eighty":9.317241,"marketCap":553129980},{"date":"2021-03-12","current":10.400664,"twenty":1.953215,"median":4.601433,"eighty":9.361164,"marketCap":659696307},{"date":"2021-03-19","current":11.042064,"twenty":1.961921,"median":4.622901,"eighty":9.424224,"marketCap":700293003},{"date":"2021-03-26","current":9.04649,"twenty":1.96442,"median":4.63729,"eighty":9.438537,"marketCap":570891035},{"date":"2021-04-01","current":3.967248,"twenty":1.973018,"median":4.623968,"eighty":9.430511,"marketCap":579381903},{"date":"2021-04-09","current":3.769324,"twenty":1.979189,"median":4.609564,"eighty":9.424508,"marketCap":551551331},{"date":"2021-04-16","current":3.234782,"twenty":1.981324,"median":4.600302,"eighty":9.421077,"marketCap":475649772},{"date":"2021-04-23","current":3.274103,"twenty":1.983504,"median":4.594129,"eighty":9.399256,"marketCap":483239928},{"date":"2021-04-30","current":3.503774,"twenty":1.992131,"median":4.576016,"eighty":9.381766,"marketCap":518830805},{"date":"2021-05-07","current":3.345251,"twenty":1.997888,"median":4.559967,"eighty":9.365612,"marketCap":498583750},{"date":"2021-05-14","current":3.211397,"twenty":2.013914,"median":4.548275,"eighty":9.32711,"marketCap":478336694},{"date":"2021-05-21","current":3.515608,"twenty":2.035612,"median":4.542259,"eighty":9.288573,"marketCap":523892569},{"date":"2021-05-28","current":3.479656,"twenty":2.049113,"median":4.537043,"eighty":9.254986,"marketCap":523892569},{"date":"2021-06-04","current":3.679868,"twenty":2.056273,"median":4.530427,"eighty":9.23165,"marketCap":551732271},{"date":"2021-06-11","current":3.563713,"twenty":2.061219,"median":4.514509,"eighty":9.212368,"marketCap":534016097},{"date":"2021-06-18","current":2.275344,"twenty":2.061219,"median":4.502956,"eighty":9.203999,"marketCap":678276370},{"date":"2021-06-25","current":2.191357,"twenty":2.056273,"median":4.491079,"eighty":9.196938,"marketCap":652967550},{"date":"2021-07-02","current":1.87323,"twenty":2.046808,"median":4.479655,"eighty":9.160587,"marketCap":556794035},{"date":"2021-07-09","current":1.730432,"twenty":2.024506,"median":4.46865,"eighty":9.119037,"marketCap":513769041},{"date":"2021-07-16","current":1.662239,"twenty":1.98682,"median":4.463577,"eighty":9.110495,"marketCap":493521986},{"date":"2021-07-23","current":1.586083,"twenty":1.97535,"median":4.450513,"eighty":9.101009,"marketCap":470744048},{"date":"2021-07-30","current":1.53875,"twenty":1.950793,"median":4.445107,"eighty":9.084999,"marketCap":458089638},{"date":"2021-08-06","current":1.552306,"twenty":1.869705,"median":4.442504,"eighty":9.050979,"marketCap":460620520},{"date":"2021-08-13","current":1.363504,"twenty":1.777939,"median":4.417738,"eighty":9.042899,"marketCap":404941116},{"date":"2021-08-20","current":1.283065,"twenty":1.747325,"median":4.38053,"eighty":9.023933,"marketCap":379632297},{"date":"2021-08-27","current":1.300955,"twenty":1.735308,"median":4.371685,"eighty":9.001366,"marketCap":404941116},{"date":"2021-09-03","current":1.403066,"twenty":1.725747,"median":4.364162,"eighty":8.979599,"marketCap":437842582},{"date":"2021-09-10","current":1.335883,"twenty":1.705998,"median":4.3515,"eighty":8.958924,"marketCap":417595526},{"date":"2021-09-17","current":1.340381,"twenty":1.689297,"median":4.343939,"eighty":8.938442,"marketCap":417595526},{"date":"2021-09-24","current":1.23478,"twenty":1.666673,"median":4.335386,"eighty":8.908672,"marketCap":384694060},{"date":"2021-10-01","current":1.206741,"twenty":1.651695,"median":4.321627,"eighty":8.904129,"marketCap":377101415},{"date":"2021-10-08","current":1.319613,"twenty":1.642989,"median":4.309588,"eighty":8.904051,"marketCap":412533762},{"date":"2021-10-15","current":1.261176,"twenty":1.63643,"median":4.279097,"eighty":8.895162,"marketCap":394817588},{"date":"2021-10-22","current":1.475957,"twenty":1.622789,"median":4.248476,"eighty":8.878523,"marketCap":465682284},{"date":"2021-10-29","current":1.343957,"twenty":1.612811,"median":4.241881,"eighty":8.8482,"marketCap":422657290},{"date":"2021-11-05","current":1.334535,"twenty":1.602824,"median":4.216939,"eighty":8.777134,"marketCap":420126408},{"date":"2021-11-12","current":1.386525,"twenty":1.586083,"median":4.210169,"eighty":8.758487,"marketCap":437842582},{"date":"2021-11-19","current":1.219827,"twenty":1.571444,"median":4.181522,"eighty":8.71027,"marketCap":384694060},{"date":"2021-11-26","current":1.172466,"twenty":1.565489,"median":4.172071,"eighty":8.704674,"marketCap":369508769},{"date":"2021-12-03","current":0.993357,"twenty":1.547798,"median":4.150379,"eighty":8.670525,"marketCap":313829365},{"date":"2021-12-10","current":1.12025,"twenty":1.526625,"median":4.120261,"eighty":8.649487,"marketCap":354323477},{"date":"2021-12-17","current":1.090651,"twenty":1.513291,"median":4.096041,"eighty":8.570458,"marketCap":227171966},{"date":"2021-12-23","current":1.226168,"twenty":1.507688,"median":4.064994,"eighty":8.551028,"marketCap":255619079},{"date":"2021-12-31","current":1.173249,"twenty":1.493501,"median":4.041014,"eighty":8.545412,"marketCap":245267772},{"date":"2022-01-07","current":1.23969,"twenty":1.483167,"median":4.018638,"eighty":8.539701,"marketCap":258149961},{"date":"2022-01-14","current":1.283356,"twenty":1.472808,"median":3.996998,"eighty":8.523772,"marketCap":268273489},{"date":"2022-01-21","current":1.141622,"twenty":1.457851,"median":3.988936,"eighty":8.508926,"marketCap":239168347},{"date":"2022-01-28","current":1.053331,"twenty":1.44714,"median":3.979444,"eighty":8.488011,"marketCap":219908335},{"date":"2022-02-04","current":1.162555,"twenty":1.426053,"median":3.967188,"eighty":8.464405,"marketCap":242711581},{"date":"2022-02-11","current":1.199378,"twenty":1.413906,"median":3.942635,"eighty":8.453313,"marketCap":250607933},{"date":"2022-02-18","current":1.097087,"twenty":1.39743,"median":3.939304,"eighty":8.437152,"marketCap":230310260},{"date":"2022-02-25","current":1.008908,"twenty":1.387125,"median":3.918967,"eighty":8.420457,"marketCap":212087909},{"date":"2022-03-04","current":0.908009,"twenty":1.367808,"median":3.907082,"eighty":8.399056,"marketCap":190828501},{"date":"2022-03-11","current":0.869861,"twenty":1.363727,"median":3.88232,"eighty":8.372883,"marketCap":182223502},{"date":"2022-03-18","current":2.787669,"twenty":1.357838,"median":3.876736,"eighty":8.339036,"marketCap":258149961},{"date":"2022-03-25","current":3.336423,"twenty":1.35913,"median":3.866977,"eighty":8.316599,"marketCap":308767601},{"date":"2022-04-01","current":3.389728,"twenty":1.362482,"median":3.852155,"eighty":8.28079,"marketCap":313829365},{"date":"2022-04-08","current":3.444999,"twenty":1.363727,"median":3.83615,"eighty":8.259061,"marketCap":318891129},{"date":"2022-04-14","current":3.013824,"twenty":1.364618,"median":3.815106,"eighty":8.239513,"marketCap":278397017},{"date":"2022-04-22","current":2.765355,"twenty":1.365216,"median":3.792152,"eighty":8.223331,"marketCap":250557316},{"date":"2022-04-29","current":3.058969,"twenty":1.365918,"median":3.769324,"eighty":8.171844,"marketCap":272672787},{"date":"2022-05-06","current":2.828864,"twenty":1.366925,"median":3.715418,"eighty":8.148875,"marketCap":249975302},{"date":"2022-05-13","current":2.211076,"twenty":1.371339,"median":3.703028,"eighty":8.125714,"marketCap":191880850},{"date":"2022-05-20","current":2.2673,"twenty":1.379889,"median":3.673757,"eighty":8.037983,"marketCap":199556084},{"date":"2022-05-27","current":2.096332,"twenty":1.382511,"median":3.648946,"eighty":8.030691,"marketCap":184331853},{"date":"2022-06-03","current":2.359877,"twenty":1.385722,"median":3.622937,"eighty":7.960473,"marketCap":208720919},{"date":"2022-06-10","current":2.330771,"twenty":1.388925,"median":3.617264,"eighty":7.939299,"marketCap":204656075},{"date":"2022-06-17","current":-53.377821,"twenty":1.370456,"median":3.60663,"eighty":7.827996,"marketCap":254999551},{"date":"2022-06-24","current":-57.897972,"twenty":1.364977,"median":3.600751,"eighty":7.800209,"marketCap":277722283},{"date":"2022-07-01","current":-65.908222,"twenty":1.358097,"median":3.577552,"eighty":7.791874,"marketCap":315593503},{"date":"2022-07-08","current":-61.093466,"twenty":1.356202,"median":3.560157,"eighty":7.775858,"marketCap":292870771},{"date":"2022-07-15","current":-63.27086,"twenty":1.346881,"median":3.54788,"eighty":7.722016,"marketCap":300445015},{"date":"2022-07-22","current":-61.624682,"twenty":1.339656,"median":3.542243,"eighty":7.650027,"marketCap":292870771},{"date":"2022-07-29","current":-59.967811,"twenty":1.335074,"median":3.524398,"eighty":7.62701,"marketCap":285296527},{"date":"2022-08-05","current":-59.057527,"twenty":1.329074,"median":3.509691,"eighty":7.610735,"marketCap":280247031},{"date":"2022-08-12","current":-57.299923,"twenty":1.30399,"median":3.480521,"eighty":7.56646,"marketCap":272672787},{"date":"2022-08-19","current":-57.399968,"twenty":1.294829,"median":3.474363,"eighty":7.529188,"marketCap":270148039},{"date":"2022-08-26","current":-55.693437,"twenty":1.28847,"median":3.451858,"eighty":7.459046,"marketCap":260049047},{"date":"2022-09-02","current":-50.865077,"twenty":1.282236,"median":3.439352,"eighty":7.329916,"marketCap":236543642},{"date":"2022-09-09","current":-4.427371,"twenty":1.27284,"median":3.41825,"eighty":7.262178,"marketCap":232276818},{"date":"2022-09-16","current":-4.711862,"twenty":1.26766,"median":3.389728,"eighty":7.055763,"marketCap":244900558},{"date":"2022-09-23","current":-4.507036,"twenty":1.255102,"median":3.334228,"eighty":6.430231,"marketCap":229752070},{"date":"2022-09-30","current":-4.449063,"twenty":1.241844,"median":3.305952,"eighty":6.36321,"marketCap":227227322},{"date":"2022-10-07","current":-4.649044,"twenty":1.233685,"median":3.272439,"eighty":6.315153,"marketCap":237427304},{"date":"2022-10-14","current":-4.397095,"twenty":1.224175,"median":3.258319,"eighty":6.268831,"marketCap":222177826},{"date":"2022-10-21","current":-4.517358,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226697125},{"date":"2022-10-28","current":-4.17876,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":209352106},{"date":"2022-11-04","current":-4.316899,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":218365457},{"date":"2022-11-11","current":-4.435179,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226747620},{"date":"2022-11-18","current":-4.188263,"twenty":1.206309,"median":3.214152,"eighty":6.038554,"marketCap":213745168},{"date":"2022-11-25","current":-1.441004,"twenty":1.196321,"median":3.183506,"eighty":5.919731,"marketCap":184306606},{"date":"2022-12-02","current":-1.739144,"twenty":1.190341,"median":3.139792,"eighty":5.695609,"marketCap":227227322},{"date":"2022-12-09","current":-1.627951,"twenty":1.184355,"median":3.058969,"eighty":5.613624,"marketCap":214628830},{"date":"2022-12-16","current":-1.787897,"twenty":1.173368,"median":3.004667,"eighty":5.573461,"marketCap":235205526},{"date":"2022-12-23","current":-1.845396,"twenty":1.166568,"median":2.973405,"eighty":5.526558,"marketCap":242224325},{"date":"2022-12-30","current":-1.809474,"twenty":1.152461,"median":2.926816,"eighty":5.501262,"marketCap":240608487},{"date":"2023-01-06","current":-2.145642,"twenty":1.147922,"median":2.899588,"eighty":5.479696,"marketCap":287821275},{"date":"2023-01-13","current":-2.06881,"twenty":1.140337,"median":2.875567,"eighty":5.427519,"marketCap":282771779},{"date":"2023-01-20","current":-2.016512,"twenty":1.137891,"median":2.86131,"eighty":5.392337,"marketCap":272672787},{"date":"2023-01-27","current":-2.259537,"twenty":1.116984,"median":2.824171,"eighty":5.370803,"marketCap":305494511},{"date":"2023-02-03","current":-2.34562,"twenty":1.101853,"median":2.781782,"eighty":5.34608,"marketCap":318118251},{"date":"2023-02-10","current":-2.473528,"twenty":1.090277,"median":2.763282,"eighty":5.316369,"marketCap":333266739},{"date":"2023-02-17","current":-2.533318,"twenty":1.079518,"median":2.732178,"eighty":5.287677,"marketCap":338316236},{"date":"2023-02-24","current":-5.725247,"twenty":1.056339,"median":2.690651,"eighty":5.254644,"marketCap":297920267},{"date":"2023-03-03","current":-5.828855,"twenty":1.037848,"median":2.654874,"eighty":5.22864,"marketCap":305494511},{"date":"2023-03-10","current":-5.456639,"twenty":1.023348,"median":2.647052,"eighty":5.204033,"marketCap":285296527},{"date":"2023-03-17","current":-5.667715,"twenty":1.001884,"median":2.632757,"eighty":5.155718,"marketCap":297920267},{"date":"2023-03-24","current":-5.748207,"twenty":0.988622,"median":2.592496,"eighty":5.123544,"marketCap":302969763},{"date":"2023-03-31","current":-5.74963,"twenty":0.981636,"median":2.560383,"eighty":5.106116,"marketCap":302969763},{"date":"2023-04-06","current":-5.611278,"twenty":0.961891,"median":2.541113,"eighty":5.097377,"marketCap":295395519},{"date":"2023-04-14","current":-5.65364,"twenty":0.948412,"median":2.488418,"eighty":5.048439,"marketCap":297920267},{"date":"2023-04-21","current":-6.231763,"twenty":0.935717,"median":2.439054,"eighty":5.022245,"marketCap":328217243},{"date":"2023-04-28","current":-5.892181,"twenty":0.913999,"median":2.35477,"eighty":4.997161,"marketCap":308019259},{"date":"2023-05-05","current":-5.53935,"twenty":0.906432,"median":2.330771,"eighty":4.985267,"marketCap":290119614},{"date":"2023-05-12","current":-5.396481,"twenty":0.890665,"median":2.309302,"eighty":4.971094,"marketCap":281123657},{"date":"2023-05-19","current":-5.468089,"twenty":0.873834,"median":2.26799,"eighty":4.953015,"marketCap":281123657},{"date":"2023-05-26","current":-5.890594,"twenty":0.84026,"median":2.223866,"eighty":4.941783,"marketCap":301364560},{"date":"2023-06-02","current":-6.08478,"twenty":0.822461,"median":2.20614,"eighty":4.930121,"marketCap":310360517},{"date":"2023-06-09","current":-7.997073,"twenty":0.753762,"median":2.191357,"eighty":4.862414,"marketCap":407067056},{"date":"2023-06-16","current":14.961744,"twenty":0.730045,"median":2.189117,"eighty":4.854051,"marketCap":409316045},{"date":"2023-06-23","current":16.549358,"twenty":0.725764,"median":2.188964,"eighty":4.847095,"marketCap":449797852},{"date":"2023-06-30","current":16.548854,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":445299873},{"date":"2023-07-07","current":16.798434,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-07-14","current":18.049358,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":492528647},{"date":"2023-07-21","current":17.617452,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-07-28","current":18.520305,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":503773594},{"date":"2023-08-04","current":19.822164,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":539757422},{"date":"2023-08-11","current":20.546635,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":555500347},{"date":"2023-08-18","current":18.151135,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":485781680},{"date":"2023-08-25","current":19.54183,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":524014497},{"date":"2023-09-01","current":21.080767,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":566745293},{"date":"2023-09-08","current":17.988448,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":440801894},{"date":"2023-09-15","current":18.317701,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-09-22","current":18.211445,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":447548862},{"date":"2023-09-29","current":19.475841,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-10-06","current":18.743843,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":461042798},{"date":"2023-10-13","current":18.65139,"twenty":0.721483,"median":2.188811,"eighty":4.867143,"marketCap":458793809},{"date":"2023-10-20","current":17.497268,"twenty":0.721483,"median":2.188811,"eighty":4.934175,"marketCap":429556948},{"date":"2023-10-27","current":16.217847,"twenty":-0.124554,"median":2.185731,"eighty":4.941783,"marketCap":398071099},{"date":"2023-11-03","current":15.850472,"twenty":-0.124554,"median":2.185731,"eighty":4.959403,"marketCap":389075141},{"date":"2023-11-10","current":15.688202,"twenty":-0.124554,"median":2.185731,"eighty":4.984734,"marketCap":386826152},{"date":"2023-11-17","current":15.779975,"twenty":-0.124554,"median":2.185731,"eighty":5.009021,"marketCap":391324131},{"date":"2023-11-24","current":14.407243,"twenty":-0.124554,"median":2.185731,"eighty":5.031648,"marketCap":362087270},{"date":"2023-12-01","current":14.119989,"twenty":-0.124554,"median":2.185731,"eighty":5.061029,"marketCap":355340303},{"date":"2023-12-08","current":16.375706,"twenty":0.296324,"median":2.187935,"eighty":5.102649,"marketCap":411565034},{"date":"2023-12-15","current":5.13977,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":467789766},{"date":"2023-12-22","current":5.193137,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":470038755},{"date":"2023-12-29","current":5.167392,"twenty":-0.124554,"median":2.185731,"eighty":5.105888,"marketCap":470038755},{"date":"2024-01-05","current":5.271514,"twenty":-0.545433,"median":2.183526,"eighty":5.117907,"marketCap":476785723},{"date":"2024-01-12","current":5.442904,"twenty":-0.545433,"median":2.183526,"eighty":5.148286,"marketCap":492528647},{"date":"2024-01-19","current":5.433825,"twenty":-0.966311,"median":2.182901,"eighty":5.16623,"marketCap":488030669},{"date":"2024-01-26","current":5.069182,"twenty":-0.545433,"median":2.183526,"eighty":5.152858,"marketCap":458793809},{"date":"2024-02-02","current":5.346932,"twenty":-0.545433,"median":2.183526,"eighty":5.165068,"marketCap":481283701},{"date":"2024-02-09","current":5.478707,"twenty":-0.545433,"median":2.183526,"eighty":5.198595,"marketCap":494777637},{"date":"2024-02-16","current":6.309669,"twenty":-0.545433,"median":2.183526,"eighty":5.238229,"marketCap":568994282},{"date":"2024-02-23","current":6.132491,"twenty":-0.545433,"median":2.183526,"eighty":5.278851,"marketCap":551002368},{"date":"2024-03-01","current":6.129507,"twenty":-0.124554,"median":2.185731,"eighty":5.28407,"marketCap":551002368},{"date":"2024-03-08","current":5.831557,"twenty":-0.124554,"median":2.185731,"eighty":5.293518,"marketCap":524014497},{"date":"2024-03-15","current":6.107883,"twenty":-0.124554,"median":2.185731,"eighty":5.315877,"marketCap":548753379},{"date":"2024-03-22","current":103.435233,"twenty":-0.124554,"median":2.185731,"eighty":5.348813,"marketCap":562247315},{"date":"2024-03-28","current":103.41931,"twenty":-0.124554,"median":2.185731,"eighty":5.36835,"marketCap":559998325},{"date":"2024-04-05","current":99.779196,"twenty":-0.545433,"median":2.183526,"eighty":5.384537,"marketCap":539757422},{"date":"2024-04-12","current":101.071124,"twenty":-0.545433,"median":2.183526,"eighty":5.402533,"marketCap":546504390},{"date":"2024-04-19","current":93.598599,"twenty":-0.545433,"median":2.183526,"eighty":5.433865,"marketCap":506022583},{"date":"2024-04-26","current":101.175863,"twenty":-0.124554,"median":2.185731,"eighty":5.454663,"marketCap":546504390},{"date":"2024-05-03","current":100.260037,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":542006411},{"date":"2024-05-10","current":79.679719,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":431840780},{"date":"2024-05-17","current":68.485221,"twenty":-0.124554,"median":2.185731,"eighty":5.504513,"marketCap":371231547},{"date":"2024-05-24","current":60.287412,"twenty":-0.124554,"median":2.185731,"eighty":5.616715,"marketCap":325774623},{"date":"2024-05-31","current":59.936079,"twenty":-0.124554,"median":2.185731,"eighty":5.781947,"marketCap":323880585},{"date":"2024-06-07","current":57.857018,"twenty":-0.124554,"median":2.185731,"eighty":5.86056,"marketCap":312516354},{"date":"2024-06-14","current":-5.111058,"twenty":-1.39972,"median":2.182277,"eighty":5.972137,"marketCap":316304431},{"date":"2024-06-21","current":-5.791635,"twenty":-1.513498,"median":2.164796,"eighty":5.975765,"marketCap":357973278},{"date":"2024-06-28","current":-5.736583,"twenty":-1.56144,"median":2.157614,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-05","current":-5.737924,"twenty":-1.647893,"median":2.11897,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-12","current":-5.544422,"twenty":-1.785668,"median":2.096332,"eighty":5.995678,"marketCap":342820970},{"date":"2024-07-15","current":-5.480589,"twenty":-1.788185,"median":2.092657,"eighty":5.995678,"marketCap":339032893},{"date":"2024-08-02","current":-5.440877,"twenty":-1.799974,"median":2.061277,"eighty":6.054033,"marketCap":337138854},{"date":"2024-08-09","current":-5.117277,"twenty":-1.845396,"median":2.034008,"eighty":6.054033,"marketCap":320092508},{"date":"2024-08-16","current":-5.450277,"twenty":-1.902036,"median":1.990803,"eighty":6.054033,"marketCap":340926931},{"date":"2024-08-23","current":-5.548409,"twenty":-2.06444,"median":1.969537,"eighty":6.054033,"marketCap":348503085},{"date":"2024-08-30","current":-5.422274,"twenty":-2.132648,"median":1.906636,"eighty":6.054033,"marketCap":342820970},{"date":"2024-09-06","current":-5.507717,"twenty":-2.192208,"median":1.858821,"eighty":6.054033,"marketCap":348503085},{"date":"2024-09-13","current":-9.164942,"twenty":-2.305525,"median":1.754206,"eighty":6.054033,"marketCap":350397124},{"date":"2024-09-20","current":-9.248138,"twenty":-2.4266,"median":1.735942,"eighty":6.054033,"marketCap":356079239},{"date":"2024-09-27","current":-9.857249,"twenty":-2.554208,"median":1.725079,"eighty":6.054033,"marketCap":382595779},{"date":"2024-10-04","current":-10.767472,"twenty":-4.167739,"median":1.694449,"eighty":6.054033,"marketCap":416688472},{"date":"2024-10-11","current":-10.349658,"twenty":-4.226527,"median":1.67005,"eighty":6.054033,"marketCap":397748087},{"date":"2024-10-18","current":-10.261164,"twenty":-4.307673,"median":1.65115,"eighty":6.054033,"marketCap":392065971},{"date":"2024-10-25","current":-11.347424,"twenty":-4.342601,"median":1.641046,"eighty":6.054033,"marketCap":433734818},{"date":"2024-10-31","current":-11.642279,"twenty":-4.424771,"median":1.629603,"eighty":6.054033,"marketCap":445099049},{"date":"2024-11-08","current":-11.890684,"twenty":-4.437526,"median":1.614876,"eighty":6.064803,"marketCap":452675203},{"date":"2024-11-15","current":-11.580432,"twenty":-4.453178,"median":1.602824,"eighty":6.064803,"marketCap":435628857},{"date":"2024-11-22","current":-12.242757,"twenty":-4.500185,"median":1.585373,"eighty":6.064803,"marketCap":460251357},{"date":"2024-11-29","current":105.02825,"twenty":-4.500185,"median":1.585373,"eighty":6.132491,"marketCap":594728092},{"date":"2024-12-06","current":101.226386,"twenty":-4.500185,"median":1.585373,"eighty":6.322232,"marketCap":571999630},{"date":"2024-12-13","current":98.989053,"twenty":-4.500185,"median":1.585373,"eighty":7.397105,"marketCap":558741360},{"date":"2024-12-20","current":85.236807,"twenty":-4.500185,"median":1.585373,"eighty":8.248611,"marketCap":479191743},{"date":"2024-12-27","current":98.062015,"twenty":-4.500185,"median":1.585373,"eighty":8.459218,"marketCap":551165206},{"date":"2025-01-03","current":94.372016,"twenty":-4.500185,"median":1.585373,"eighty":8.718047,"marketCap":530330782},{"date":"2025-01-10","current":92.424911,"twenty":-4.501898,"median":1.584133,"eighty":8.928773,"marketCap":517072513},{"date":"2025-01-17","current":91.747806,"twenty":-4.501898,"median":1.584488,"eighty":9.39695,"marketCap":513284436},{"date":"2025-01-24","current":98.596639,"twenty":-4.501898,"median":1.601225,"eighty":9.783586,"marketCap":554953283},{"date":"2025-01-31","current":99.438002,"twenty":-4.501898,"median":1.613843,"eighty":10.562535,"marketCap":562529437},{"date":"2025-02-07","current":99.950895,"twenty":-4.501898,"median":1.625636,"eighty":11.383302,"marketCap":562529437},{"date":"2025-02-14","current":100.350725,"twenty":-4.501898,"median":1.641046,"eighty":12.297388,"marketCap":564423475},{"date":"2025-02-21","current":107.205077,"twenty":-4.501898,"median":1.647915,"eighty":12.677797,"marketCap":606092323},{"date":"2025-02-28","current":94.118612,"twenty":-4.501898,"median":1.664456,"eighty":14.155737,"marketCap":530330782},{"date":"2025-03-07","current":91.684274,"twenty":-4.50361,"median":1.691225,"eighty":14.495249,"marketCap":518966551},{"date":"2025-03-14","current":90.651653,"twenty":-4.50361,"median":1.724908,"eighty":15.427996,"marketCap":513284436},{"date":"2025-03-21","current":96.715498,"twenty":-4.50361,"median":1.734885,"eighty":15.679813,"marketCap":547377129},{"date":"2025-03-28","current":89.912948,"twenty":-4.50361,"median":1.752834,"eighty":15.814795,"marketCap":507602320},{"date":"2025-04-04","current":88.086277,"twenty":-4.50361,"median":1.851142,"eighty":15.971694,"marketCap":496238089},{"date":"2025-04-11","current":77.337205,"twenty":-4.501898,"median":1.906636,"eighty":16.218055,"marketCap":433734818},{"date":"2025-04-17","current":82.909148,"twenty":-4.501898,"median":1.979101,"eighty":16.305595,"marketCap":465933473},{"date":"2025-04-21","current":84.840561,"twenty":-4.50361,"median":1.982513,"eighty":16.352149,"marketCap":477297704}],"updateTime":1745316952438}}}